Cargando…
Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy
Quantification of Epstein-Barr virus (EBV) cell-free DNA (cfDNA) is commonly used in clinical settings as a circulating biomarker in nasopharyngeal carcinoma (NPC), but there has been no comparison with circulating tumour cells (CTCs). Our study aims to compare the performance of CTC enumeration aga...
Autores principales: | Vo, Jess Honganh, Nei, Wen Long, Hu, Min, Phyo, Wai Min, Wang, Fuqiang, Fong, Kam Weng, Tan, Terence, Soong, Yoke Lim, Cheah, Shie Lee, Sommat, Kiattisa, Low, Huiyu, Ling, Belinda, Ng, Johnson, Tan, Wan Loo, Chan, Kian Sing, Oon, Lynette, Ying, Jackie Y., Tan, Min-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431344/ https://www.ncbi.nlm.nih.gov/pubmed/28442757 http://dx.doi.org/10.1038/s41598-016-0006-3 |
Ejemplares similares
-
Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
por: Tan, Rong, et al.
Publicado: (2020) -
Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer care
por: Kong, Say Li, et al.
Publicado: (2017) -
The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients – a national cancer centre experience
por: Poh, Sharon S., et al.
Publicado: (2023) -
Single Cell Hydrodynamic Stretching and Microsieve Filtration Reveal Genetic, Phenotypic and Treatment-Related Links to Cellular Deformability
por: Li, Fenfang, et al.
Publicado: (2020) -
Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
por: Poh, Sharon Shuxian, et al.
Publicado: (2021)